rabeprazole has been researched along with Adenocarcinoma in 5 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of esophageal cancer continues to rise in the Western world." | 2.49 | Impact of inflammation-metaplasia-adenocarcinoma sequence and prevention in surgical rat models. ( Fujimura, T; Fushida, S; Harmon, JW; Hattori, T; Miwa, K; Miyashita, T; Ninomiya, I; Nishijima, K; Ohta, T; Oyama, K; Sasaki, S; Shah, FA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hikichi, T | 1 |
| Sato, M | 1 |
| Watanabe, K | 1 |
| Nakamura, J | 1 |
| Takagi, T | 1 |
| Suzuki, R | 1 |
| Sugimoto, M | 1 |
| Waragai, Y | 1 |
| Kikuchi, H | 1 |
| Konno, N | 1 |
| Ohira, H | 1 |
| Obara, K | 1 |
| Falcone, R | 1 |
| Roberto, M | 1 |
| D'Antonio, C | 1 |
| Romiti, A | 1 |
| Milano, A | 1 |
| Onesti, CE | 1 |
| Marchetti, P | 1 |
| Fais, S | 1 |
| Miyashita, T | 2 |
| Shah, FA | 2 |
| Harmon, JW | 2 |
| Marti, GP | 1 |
| Matsui, D | 1 |
| Okamoto, K | 1 |
| Makino, I | 1 |
| Hayashi, H | 1 |
| Oyama, K | 2 |
| Nakagawara, H | 1 |
| Tajima, H | 1 |
| Fujita, H | 1 |
| Takamura, H | 1 |
| Murakami, M | 1 |
| Ninomiya, I | 2 |
| Kitagawa, H | 1 |
| Fushida, S | 2 |
| Fujimura, T | 2 |
| Ohta, T | 2 |
| Miwa, K | 1 |
| Sasaki, S | 1 |
| Nishijima, K | 1 |
| Hattori, T | 1 |
| Tanaka, K | 1 |
| Toyoda, H | 1 |
| Kadowaki, S | 1 |
| Hamada, Y | 1 |
| Kosaka, R | 1 |
| Yamanaka, M | 1 |
| Imoto, I | 1 |
2 reviews available for rabeprazole and Adenocarcinoma
| Article | Year |
|---|---|
Do proton pump inhibitors protect against cancer progression in GERD?
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Barrett Esop | 2013 |
Impact of inflammation-metaplasia-adenocarcinoma sequence and prevention in surgical rat models.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Disease Models, Animal; Disease Pr | 2013 |
1 trial available for rabeprazole and Adenocarcinoma
| Article | Year |
|---|---|
Oral rabeprazole administration on a procedure day suppresses bleeding after endoscopic submucosal dissection for gastric neoplasms.
Topics: Adenocarcinoma; Adenoma; Administration, Oral; Aged; Aged, 80 and over; Female; Gastrointestinal Hem | 2014 |
2 other studies available for rabeprazole and Adenocarcinoma
| Article | Year |
|---|---|
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Colorectal Neoplasms; Humans; Male; Neoplasm Metastasis | 2016 |
Use of proton pump inhibitors may cause squamous epithelial masking of intramucosal carcinoma in Barrett's esophagus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Barrett Esophagus; Biopsy; Diagnostic | 2007 |